866-997-4948(US-Canada Toll Free)

Renal Denervation Devices (Symplicity, EnligHTN, OneShot, V2, Paradise, TIVUS, Bullfrog, Surround Sound, Micro-Infusion, Ultrasound And Radiofrequency) Market - Global Industry Analysis, Size, Share, Growth, And Forecast, 2012 - 2021

Published By :

Transparency

Published Date : Feb 2013

Category :

Ultrasound

No. of Pages : 70 Pages


The study comprises of a strategic analysis of the global market for renal denervation devices, and growth forecast for the period from 2012 – 2021. The scope of the report includes competitive analysis of various market segments based on the product, technology and in-depth scrutiny for different regional markets such as North America, Europe, Asia-Pacific and the rest of the world. The Porter’s Five Forces analysis included in the report provides an insight into market dynamics and industry competition. The report also offers a PESTLE analysis on the market segments with regards to the future, segregated in different chapters. The report details across from 2012 to 2021 which includes the information of all projected activities in every phase of the report. The market forecast has been separated in three groups of years (2012-2015, 2015-2018 and 2018-2021) to include a separate analysis of each group. The unique analysis in this way covers all current and predicted future activities though this period and highlights key milestones in the progress of this market in the coming years. 

This report provides complete insights on the RDN devices market and also analyzes various factors responsible for market growth. These factors determine various existing trends and their impact on market growth. In all, the report includes a holistic analysis of the global renal denervation devices market, and provides an estimate of growth for the period 2012 – 2021, keeping in mind the various factors affecting the market. 

This report also analyzes current trends for hypertension treatment methods and advantages of renal denervation systems over other methods which act as a catalyst for the growth in the market. The report provides analysis of the most popular RDN device platforms such as Medtronic’s Symplicity, Covidien’s OneShot, Boston Scientific’s (Vessix Vascular) V2 system, and other emerging devices which will enable stakeholders to map their strategies. 

The report also analyzes growth strategies implemented by existing players which will guide emerging players to develop their own strategies and helps existing players to structure their planning process. The report also includes entry barriers to be considered to cater to the exact business opportunities in this market. Additionally, to aid in tactical decision making, the report also includes competitive profiling of leading players, recent developments in the industry and various business strategies adopted by them. This report will help manufacturers, suppliers and distributors in the renal denervation field to plan and implement their roadmap in different market areas such as emerging geographies and new technologies.

1.2 Renal Denervation Devices: Market Segmentation

The study segments the market by technologies used for denervation such as Radiofrequency, Ultrasound, Micro-infusion of drugs (Chemical) and radiation. The report also segments the market according to the brand of products available in the market, particularly, Symplicity, EnligHTN, OneShot, V2 and others. Finally the report has given an in-depth analysis of the epidemiology, growth drivers and restraints by geography in the final section.
Table of Content

Chapter 1 Introduction
1.1 Research scope and description
1.2 Renal Denervation Devices: Market Segmentation
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research
1.3.1.2 Primary Research
1.4 Assumptions

Chapter 2 Executive Summary

Chapter 3 Global Renal Denervation Devices Market Analysis
3.1 Background
3.1.1 Hypertension
3.1.2 Treatment resistant hypertension (trHTN) & uncontrolled hypertension (uHTN)
3.1.3 Current trends in resistant hypertension treatment
3.1.4 Role of renal sympathetic nerves in hypertension
3.1.5 Renal denervation treatment
3.1.6 Risks associated with renal denervation
3.2 Market Drivers For Renal Denervation
3.2.1 Increasing cases of uncontrolled and treatment resistant or drug resistant hypertension (trHTN) driving the market
3.2.2 Short duration and permanent effect of renal denervation procedure is expected to drive the market
3.2.3 Rapid development of RDN devices and aging population globally growing at parallel levels to drive the market
3.3 Market Restraints For Renal Denervation
3.3.1 Shortage of clinical evidence restraining the expansion of the market
3.3.2 Lower awareness of RDN devices as compared to drug-based therapy
3.3.3 Unstable reimbursement regulations expected to be another barrier for RDN devices
3.4 Opportunities in Renal Denervation Market
3.4.1 Emerging economies to be high growth opportunity regions
3.4.2 Merger and acquisition opportunities
3.5 Porters Five Forces Analysis
3.5.1 Bargaining power of suppliers
3.5.2 Bargaining power of buyers
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Competitive rivalry
3.6 Market Attractiveness Analysis: Global Renal Denervation Devices Market, by Geography, Scenario in 2021

Chapter 4 Global Renal Denervation Devices Market Analysis, By Technology
4.1 Renal Sympathetic Denervation Procedure
4.1.1 Overview
4.1.2 Trends in renal denervation technologies
4.2 Radiofrequency-based Renal Denervation Systems (RF-RDN)
4.2.1 Overview
4.2.2 Market Trends
4.3 Ultrasound-based Renal Denervation Systems (US-RDN)
4.3.1 Market Trends
4.4 Micro-infusion catheter-based Renal Denervation Systems
4.4.1 Overview
4.4.2 Market trends

Chapter 5 Global Renal Denervation Devices Market Analysis, By Products
5.1 Medtronic - Symplicity Renal Denervation System
5.1.1 Product Description
5.1.2 Market Trends
5.2 St.Jude Medical - EnligHTN Multi-Electrode Renal Denervation System
5.2.1 Product Description
5.2.2 Market Trends
5.3 Covidien - OneShot
5.3.1 Product Overview
5.3.2 Market Trends
5.4 Boston Scientific (Vessix Vascular) – V2 Renal Denervation System
5.4.1 Product Description
5.4.2 Market Trends
5.5 ReCor Medical – PARADISE Technology (Percutaneous Renal Denervation System)
5.5.1 Product Overview
5.5.2 Market Trends
5.6 Other Emerging Technologies
5.6.1 Kona Medical – Surround Sound Renal Denervation System
5.6.2 CardioSonic - TIVUS
5.6.3 Mercator – Bullfrog Micro-Infusion Catheters
5.6.4 Sound Interventions – Sound 360

Chapter 6 Renal Denervation Market Analysis, By Geography
6.1 Overview
6.1.1 Global Renal Denervation Devices Market, By Geography, 2012 - 2021 (USD Million)
6.2 North America
6.2.1 North America Renal Denervation Devices Market, 2012 - 2021 (USD Million)
6.3 Europe
6.3.1 Europe Renal Denervation Devices Market, 2012 - 2021 (USD Million)
6.4 Asia-Pacific
6.4.1 Asia-Pacific Renal Denervation Devices Market, 2012 - 2021 (USD Million)
6.5 Rest of the World
6.5.1 RoW Renal Denervation Devices Market, 2012 - 2021 (USD Million)

Chapter 7 Competitive Analysis: Renal Denervation Market
7.1 Market Share of Key Players: Comparative Analysis, 2012 & 2015
7.2 Competitive Landscape: Company Profiles
7.2.1 Medtronic Inc.
7.2.1.1 Company Overview
7.2.1.2 Financial Analysis
7.2.1.3 Strategies
7.2.1.3.1 Merger & Acquisition Strategies
7.2.1.3.2 New Product development
7.2.1.4 Product Portfolio
7.2.1.5 Recent Developments
7.2.2 Kona Medical
7.2.2.1 Company Overview
7.2.2.2 Financial Analysis
7.2.2.3 Strategies
7.2.2.3.1 Investment through venture capitalists
7.2.2.4 Product Portfolio
7.2.2.5 Recent Developments
7.2.3 St.Jude Medical
7.2.3.1 Company Overview
7.2.3.2 Financial Analysis
7.2.3.3 Strategies
7.2.3.3.1 Significant R&D investment for quality product development
7.2.3.3.2 Global Expansion with technology advancement
7.2.3.4 Product Portfolio
7.2.3.5 Recent Developments
7.2.4 Boston Scientific Corporation
7.2.4.1 Company Overview
7.2.4.2 Financial Analysis
7.2.4.3 Product Portfolio
7.2.4.4 Strategies
7.2.4.4.1 Merger and Acquisitions
7.2.4.4.2 New Product Development
7.2.4.4.3 Recent Developments
7.2.5 Covidien PLC
7.2.5.1 Company Overview
7.2.5.2 Financial Overview
7.2.5.3 Product Portfolio
7.2.5.4 Business Strategies
7.2.5.4.1 Focused research and development activities
7.2.5.4.2 New Product development
7.2.5.4.3 Merger and acquisition
7.2.5.5 Recent Developments
7.2.6 Mercator Medsystems
7.2.6.1 Company Overview
7.2.6.2 Product Portfolio
7.2.6.3 Business Strategies
7.2.6.3.1 Strategic partnership
7.2.6.3.2 Develop advanced technology products
7.2.7 CardioSonic
7.2.7.1 Company Overview
7.2.7.2 Product Portfolio
7.2.7.3 Recent Developments

List of Table

List of Tables

TABLE 1 Renal Denervation Devices – Market Snapshot
TABLE 2 RDN devices market size and forecast, by technology, 2012 – 2015 (USD million)
TABLE 3 RDN devices market size and forecast, by technology, 2015 – 2018 (USD million)
TABLE 4 RDN devices market size and forecast, by technology, 2018 – 2021 (USD million)
TABLE 5 Comparative Analysis of Energy Sources in Renal Denervation Devices
TABLE 6 RDN devices market size and forecast, by products, 2012 – 2015 (USD million)
TABLE 7 RDN devices market size and forecast, by products, 2015 – 2018 (USD million)
TABLE 8 RDN devices market size and forecast, by products, 2018 – 2021 (USD million)
TABLE 9 RDN devices market size and forecast, by geography, 2012 – 2015 (USD million)
TABLE 10 RDN devices market size and forecast, by geography, 2015 – 2018 (USD million)
TABLE 11 RDN devices market size and forecast, by geography, 2018 – 2021 (USD million)

List of Chart

List of Figures 

FIG. 1 Renal Denervation Devices: Market Segmentation
FIG. 2 Global Renal Denervation Devices Market, 2012 - 2021 (USD Million)
FIG. 3 Comparative Analysis: Global Renal Denervation Devices Market, by Products, 2016 & 2021 (%)
FIG. 4 Porter’s Five Forces Analysis: Renal Denervation Devices Market
FIG. 5 Market Attractiveness Analysis: Global Renal Denervation Devices Market, by Geography, 2021
FIG. 6 Global Renal Denervation Devices Market, By Geography, 2012 - 2021 (USD Million)
FIG. 7 North America Renal Denervation Devices Market, 2012 - 2021 (USD Million)
FIG. 8 Europe Renal Denervation Devices Market, 2012 - 2021 (USD Million)
FIG. 9 Asia-Pacific Renal Denervation Devices Market, 2012 - 2021 (USD Million)
FIG. 10 RoW Renal Denervation Devices Market, 2012 - 2021 (USD Million)
FIG. 11 Comparative Analysis: Market Share of Key Players (2012 & 2015)
FIG. 12 Comparative Analysis: Market Share of Key Players (2015 & 2018)
FIG. 13 Comparative Analysis: Market Share of Key Players (2018 & 2021)
FIG. 14 Medtronic Inc.: Annual Revenues, 2010 - 2012 (USD Million)
FIG. 15 St.Jude Medical: Annual Revenues, 2009 - 2011 (USD Million)
FIG. 16 Boston Scientific Corporation: Annual Revenues, 2010 - 2012 (USD Million)
FIG. 17 Covidien PLC: Annual Revenues, 2010 - 2012 (USD Million)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *